Drug Profile


Alternative Names: Aspirin/sumatriptan 325/12.5; VVD 101

Latest Information Update: 11 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Vivid Pharma Inc
  • Class Antimigraines; Indoles; Nonsteroidal anti-inflammatories; Salicylic acids; Small molecules; Sulfonamides; Tryptamines
  • Mechanism of Action Cyclooxygenase inhibitors; Serotonin 1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Suspended Headache

Most Recent Events

  • 11 Apr 2017 Suspended - Phase-II for Headache (delayed alcohol induced) in USA (PO)
  • 01 Jan 2016 Vivid Pharma completes a phase II trial in Headache (delayed alcohol indced) in USA (NCT02176655)
  • 01 Jul 2014 Phase-II clinical trials in Headache (delayed alcohol induced) in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top